Related Experiment Video

Updated: May 18, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis

Thomas D Koepsell1, Sarah E Monsell

  • 1Department of Epidemiology and Health Services, University of Washington, Seattle, USA.

Neurology
|September 29, 2012
PubMed
Abstract

Insights

Mild cognitive impairment (MCI) can revert to normal cognition in about 16% of cases. However, individuals who revert still face an increased risk of future cognitive decline, underscoring the need for continued monitoring.

Area of Science:

  • Neurology
  • Cognitive Science
  • Geriatrics

Background:

  • Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia.
  • Understanding factors associated with MCI reversion and subsequent cognitive decline is crucial for patient management.

Purpose of the Study:

  • To identify predictors of reversion from MCI to normal cognition.
  • To estimate the risk of future cognitive decline in individuals who revert from MCI.

Main Methods:

  • Analysis of 3,020 individuals diagnosed with MCI at US Alzheimer's Disease Centers.
  • Logistic regression to identify reversion predictors (MMSE, CDR, MCI type, FAQ, APOE ε4).
  • Survival analysis to assess 3-year risk of MCI or dementia post-reversion.

Main Results:

  • Approximately 16% of individuals with MCI reverted to normal cognition within a year.
  • Key predictors of reversion included MMSE, CDR, MCI type, FAQ, and APOE ε4 status.
  • Reverted individuals showed a sharply elevated risk of retransitioning to MCI or dementia within 3 years.

Conclusions:

  • Reversion from MCI is relatively common, even in specialized centers.
  • Individuals who revert from MCI remain at an elevated risk for subsequent cognitive decline.
  • These findings highlight the dynamic nature of MCI and the importance of long-term follow-up.

More Related Videos

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...